WEBSITECHANGES

Website Changes

---

02/23/2022

Creating a Precision Oncology Platform Trial for Brain Cancer

---

02/20/2022

Convection enhanced delivery of the oncolytic adenovirus Delta24-RGD in recurrent GBM patients; a phase I clinical trial including correlative studies

---

02/13/2022

Socioeconomic factors affecting survivorship of glioblastoma patients in the Philippines

---

02/11/2022

Teenager with brain tumour flies home after failed US cancer trial leaves family with £370,000 bill

---

02/10/2022

‘Decision switch’ Discovered in Mutations Linked to Common Brain Tumor

---

02/09/2022

Musella Foundation awards $50,000 brain tumor research grant!

---

02/09/2022

"Rare Enough" One man`s story about his battle with a Glioblastoma

---

02/06/2022

Promising Treatment for Deadly Brain Cancer

---

02/06/2022

The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns

---

01/29/2022

GammaTile® brachytherapy in the treatment of recurrent glioblastomas

---

01/28/2022

Are cancer patients better off if they participate in clinical trials? A mixed methods study

---

01/24/2022

Mark Cuban Cost Plus Drug Company`s Online Pharmacy Launches with Lowest Prices on 100 Lifesaving Prescriptions

---

01/22/2022

Results of a post hoc analysis of the EF-14 study showed Optune + TMZ was associated with increased median OS vs TMZ alone in patients ineligible for surgical resection

---

01/20/2022

Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab

---

01/20/2022

Vigeo Therapeutics Advances VT1021 Into Phase 2-3 Registrational Study for Glioblastoma

---

01/13/2022

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models

---

01/07/2022

Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients

---

01/07/2022

Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review

---

01/07/2022

Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study

---

01/06/2022

DIPG All-In-Initiative awards $35,000 grant for pediatric brain tumor research!

---

01/04/2022

Efficacy and safety of bevacizumab combined with other therapeutic regimens for treatment of recurrent glioblastoma: A network meta-analysis

---

01/04/2022

Musella Foundation Copay Assistance Program is now open!

---

01/04/2022

Drug Resistance in Glioma Cells Induced by a Mesenchymal–Amoeboid Migratory Switch

---

01/03/2022

Combination therapies for pediatric brain tumors

---

01/01/2022

Musella Foundation awards $25,000 brain tumor research grant!

---